LONDON, UK—-29th April 2010—-New Publications. Today VacZine Analytics releases a new publication investigating the epidemiology and burden of the hospital pathogen Clostridium difficile in “Rest of World” and emerging markets. The publication continues the longstanding company interest in C.diff and takes a further step to understanding the impact of the pathogen globally.DiseaseINFOPACK: Clostridium difficile – Rest of World/emerging markets is being complimented by primary research with global experts throughout the year. VISIT SITE TO LEARN MORE.
